The VR2 Epitope on the PorA P1.7-2,4 Protein Is the Major Target for the Immune Response Elicited by the Strain-Specific Group B Meningococcal Vaccine MeNZB

• Published in: Clinical and Vaccine Immunology Vol. 13; no. 4; pp. 486 - 491
• Main Authors: Martin, D R, Ruijne, N, McCallum, L, O'Hallahan, J, Oster, P
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 01.04.2006
• Subjects: Amino Acid Sequence; Antibodies, Bacterial - biosynthesis; Antibodies, Bacterial - blood; Child; Child, Preschool; Epitopes - genetics; Epitopes - immunology; Humans; Infant; Meningococcal Infections - immunology; Meningococcal Infections - microbiology; Meningococcal Infections - prevention & control; Meningococcal Vaccines - genetics; Meningococcal Vaccines - immunology; Molecular Sequence Data; Neisseria meningitidis; Neisseria meningitidis - genetics; Neisseria meningitidis - immunology; Neisseria meningitidis, Serogroup B - immunology; Porins - genetics; Porins - immunology; Randomized Controlled Trials as Topic; Sequence Deletion; Vaccine Research
• ISSN: 1556-6811; 1556-679X
• DOI: 10.1128/CVI.13.4.486-491.2006

Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy CVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 1556-6811 Online ISSN: 1556-679X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to CVI .asm.org, visit: CVI